Thursday, November 30, 2023 8:55:15 AM
For new investors or those considering to invest in LQMT here is real DD, not the conspiracy lies thrown at you in make believe land by those with their own agendas.
From joshua on reditt:
Liquidmetal partner in crime
https://www.prnewswire.com/news-releases/movano-completes-blood-pressure-study-with-110-participants-301452111.html
Well….this justify CE language change in LQMT 10k
During the study, participants wore Movano's “adjustable” full finger ring prototype and its wrist-worn wearable prototype along with a hospital-grade FDA-cleared vital signs monitor as the control.
Movano's devices collected pulse pressure waveform data, which will be compared to data from the control device in order to further its signal processing and algorithms.
Movano's proprietary integrated circuits in the wrist-worn prototype, which are supported by a radio-frequency technology platform, app and cloud infrastructure, allow Movano to calculate blood pressure, glucose, heart rate, and respiration rate estimates.
The ring prototype also has an optical sensor to estimate SpO2 measurements and an accelerometer to measure steps and calories.
Eve Ring is only the beginning
Existing Evie Ring is basically a Medical Grade Oura Ring with no monthly subscription fee.
It looks like the Holy Grail will be Cuffless Blood Pressure and Needle Free Continuous Glucose Monitoring via RF sensing at mm wave. As a result, casing itself must be RF transparent.
Good luck to all and even the CCP/Alien/Apple violation conspiracists, and all who love to gloat about their pennies from the wash rinse and repeat cycles.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM